• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极光激酶A介导c-Myc在肝细胞癌中的致癌作用。

Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.

作者信息

Lu Longfeng, Han Han, Tian Yuan, Li Wenjuan, Zhang Jinxiang, Feng Maohui, Li Youjun

机构信息

State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.

Department of Surgery, Wuhan Union Hospital, Wuhan, China.

出版信息

Mol Carcinog. 2015 Nov;54(11):1467-79. doi: 10.1002/mc.22223. Epub 2014 Oct 4.

DOI:10.1002/mc.22223
PMID:25284017
Abstract

Dysregulation of c-Myc (Myc) has been shown to contribute to progression of hepatocellular carcinoma, however, the detailed molecular mechanism remains poorly understood. Here, we report that Myc binds to the Aurora kinase A (Aurka) promoter and induces expression of Aurka in HCC cells. Increased expression of Aurka correlates with that of Myc in HCC. Nuclear accumulation of Aurka was confirmed by subcellular protein fractionation and immunoblot experiments in HCC cells. Myc inhibition decreases the nuclear accumulation of Aurka in HCC cells. Also Aurka accumulating in the nucleus up-regulates Myc transcription by binding the Myc promoter containing the highly conserved CCCTCCCCA in the NHE region of the CpG islands. Inhibition of Myc or Aurka diminishes the malignant phenotypes of HCC cells by down-regulating some common target genes. Also Aurka and Myc mediates the effects of each other, at least partially, on proliferation, anchorage-independent soft agar growth, and ATP production. Blocking Aurka in an orthotopic model significantly impairs tumor growth in mice. These results identify a Myc-Aurka feedback loop in which Myc and Aurka regulate expression of each other at the transcriptional level and both play an important role in hepatocarcinogenesis.

摘要

c-Myc(Myc)失调已被证明与肝细胞癌进展有关,然而,详细的分子机制仍知之甚少。在此,我们报告Myc与极光激酶A(Aurka)启动子结合并诱导肝癌细胞中Aurka的表达。Aurka表达增加与肝癌中Myc的表达相关。通过亚细胞蛋白质分级分离和免疫印迹实验在肝癌细胞中证实了Aurka的核积累。Myc抑制降低了肝癌细胞中Aurka的核积累。同样,在细胞核中积累的Aurka通过结合CpG岛NHE区域中含有高度保守的CCCTCCCCA的Myc启动子来上调Myc转录。抑制Myc或Aurka通过下调一些共同的靶基因来减少肝癌细胞的恶性表型。此外,Aurka和Myc至少部分地相互介导对增殖、非锚定依赖的软琼脂生长和ATP产生的影响。在原位模型中阻断Aurka可显著损害小鼠肿瘤生长。这些结果确定了一个Myc-Aurka反馈环,其中Myc和Aurka在转录水平上相互调节表达,并且两者在肝癌发生中都起重要作用。

相似文献

1
Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.极光激酶A介导c-Myc在肝细胞癌中的致癌作用。
Mol Carcinog. 2015 Nov;54(11):1467-79. doi: 10.1002/mc.22223. Epub 2014 Oct 4.
2
ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.ID1 通过放大 AURKA/Myc 信号通路促进 HCC 进展。
Int J Oncol. 2020 Sep;57(3):845-857. doi: 10.3892/ijo.2020.5092. Epub 2020 Jul 1.
3
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.联合抑制 AURKA 和 HSF1 通过激活内质网应激抑制肝癌细胞增殖并促进其凋亡。
Cell Oncol (Dordr). 2021 Oct;44(5):1035-1049. doi: 10.1007/s13402-021-00617-w. Epub 2021 Jun 26.
4
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.一个 MYC-极光激酶 A 蛋白复合物代表了 p53 改变的肝癌中一个可作用的药物靶点。
Nat Med. 2016 Jul;22(7):744-53. doi: 10.1038/nm.4107. Epub 2016 May 23.
5
Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.通过在 TTP 启动子中单 CpG 位点的表观遗传调控,在肝癌中实现 TGF-β1 信号的功能切换。
Gastroenterology. 2010 May;138(5):1898-908. doi: 10.1053/j.gastro.2009.12.044. Epub 2009 Dec 29.
6
MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.在肝癌转基因模型中鉴定出的与肝细胞发育异常相关的MYC调控基因。
J Pathol. 2012 Dec;228(4):520-33. doi: 10.1002/path.4059. Epub 2012 Nov 6.
7
Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.乙型肝炎病毒 X 蛋白通过 Sp-1/c-Myc 上调 Lin28A/Lin28B 以增强肝癌细胞的增殖。
Oncogene. 2014 Jan 23;33(4):449-60. doi: 10.1038/onc.2012.618. Epub 2013 Jan 14.
8
Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.c-Myc 对人肝细胞癌中 GPC3 的致癌激活作用。
Hepatology. 2012 Oct;56(4):1380-90. doi: 10.1002/hep.25891.
9
SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.SIX3,一种肿瘤抑制因子,通过转录抑制 AURKA/B 来抑制星形细胞瘤的发生。
J Hematol Oncol. 2017 Jun 8;10(1):115. doi: 10.1186/s13045-017-0483-2.
10
AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.AGBL2 通过 IRGM 调控的自噬和增强肝癌细胞中的 Aurora A 活性促进癌细胞生长。
Cancer Lett. 2018 Feb 1;414:71-80. doi: 10.1016/j.canlet.2017.11.003. Epub 2017 Nov 8.

引用本文的文献

1
Aurora-A promotes lenvatinib resistance experimentally through hsa-circ-0058046/miR-424-5p/FGFR1 axis in hepatocellular carcinoma.在实验中,极光激酶A通过人源环状RNA-0058046/微小RNA-424-5p/成纤维细胞生长因子受体1轴促进肝癌对乐伐替尼的耐药性。
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251316692. doi: 10.1177/03946320251316692.
2
Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics.揭示夏天无抗肝细胞癌的活性成分及作用机制:一项基于网络药理学和生物信息学的研究
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):729-746. doi: 10.1007/s00210-024-03278-2. Epub 2024 Jul 25.
3
The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer.
Aurora 激酶 A 在肝细胞癌中的作用:揭示肝癌中一个关键但仍未充分探索的因素的有趣功能。
Cell Prolif. 2024 Aug;57(8):e13641. doi: 10.1111/cpr.13641. Epub 2024 Apr 8.
4
The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect.极光激酶抑制剂 AT9283 通过调节瓦博格效应抑制 Burkitt 淋巴瘤生长。
PeerJ. 2023 Dec 11;11:e16581. doi: 10.7717/peerj.16581. eCollection 2023.
5
When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases.当只有一个磷酸盐也太多时:Myc 和激酶之间的多方面相互作用。
Int J Mol Sci. 2023 Mar 1;24(5):4746. doi: 10.3390/ijms24054746.
6
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.基于剪接转换寡核苷酸的组合平台确定了针对MYC驱动的肝细胞癌的合成致死靶点CHK1和BRD4。
Bioeng Transl Med. 2022 Sep 3;8(1):e10363. doi: 10.1002/btm2.10363. eCollection 2023 Jan.
7
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer.极光激酶在头颈部癌症中的治疗靶点。
Cancer J. 2022;28(5):387-400. doi: 10.1097/PPO.0000000000000614.
8
Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.通过综合生物信息学分析鉴定和验证肝细胞癌中预后不良的关键基因
Int J Gen Med. 2022 Apr 11;15:3933-3941. doi: 10.2147/IJGM.S353708. eCollection 2022.
9
The Relevance of Aurora Kinase Inhibition in Hematological Malignancies.极光激酶抑制在血液系统恶性肿瘤中的相关性
Cancer Diagn Progn. 2021 Jul 3;1(3):111-126. doi: 10.21873/cdp.10016. eCollection 2021 Jul-Aug.
10
A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.一种与免疫浸润相关的新型九基因特征用于预测肝细胞癌的预后
Front Genet. 2021 Nov 30;12:730732. doi: 10.3389/fgene.2021.730732. eCollection 2021.